Mainz Biomed N.V.
QUCY
$0.43
-$0.03-6.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -12.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -12.69% | |||
| Cost of Revenue | 0.00% | -48.35% | |||
| Gross Profit | 0.00% | 5.59% | |||
| SG&A Expenses | 0.00% | -29.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -32.47% | |||
| Operating Income | 0.00% | 33.17% | |||
| Income Before Tax | 0.00% | 5.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | 5.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 5.72% | |||
| EBIT | 0.00% | 33.17% | |||
| EBITDA | 0.00% | 33.63% | |||
| EPS Basic | 0.00% | 66.50% | |||
| Normalized Basic EPS | 0.00% | 78.49% | |||
| EPS Diluted | 0.00% | 66.50% | |||
| Normalized Diluted EPS | 0.00% | 78.49% | |||
| Average Basic Shares Outstanding | 0.00% | 181.43% | |||
| Average Diluted Shares Outstanding | 0.00% | 181.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||